Bayer AG and Johnson & Johnson agreed to pay $775 million to settle more than 25,000 U.S. lawsuits tied to their blood thinner Xarelto, according to Reuters. The settlement resolves all outstanding ...
Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that Pradaxa's maker, Boehringer Ingelheim Pharmaceuticals, is seeking FDA approval for its blood thinner to treat DVT and PE.